These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2453268)

  • 1. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma.
    Lönn U; Lönn S
    Cancer Res; 1988 Aug; 48(15):4153-7. PubMed ID: 2968838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Mar; 49(5):1085-9. PubMed ID: 2521812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of alpha 2-macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides.
    DiPaola M; Keith CH; Feldman D; Tycko B; Maxfield FR
    J Cell Physiol; 1984 Feb; 118(2):193-202. PubMed ID: 6319437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines.
    Lönn U; Lönn S
    Cancer Res; 1986 Aug; 46(8):3866-70. PubMed ID: 2942236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine.
    Smith PJ; Mircheva JJ; Bleehen NM
    Acta Physiol Pharmacol Bulg; 1987; 13(1):41-5. PubMed ID: 2441572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.
    Rosenthal SA; Hait WN
    Yale J Biol Med; 1988; 61(1):39-49. PubMed ID: 2452522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate.
    Huang Y; Waxman S
    Clin Cancer Res; 1998 Oct; 4(10):2503-9. PubMed ID: 9796984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced DNA hypermethylation and drug resistance in human tumors.
    Nyce J
    Cancer Res; 1989 Nov; 49(21):5829-36. PubMed ID: 2790794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of 9 beta-chloro-16, 16-dimethyl prostaglandin E2 (nocloprost) on the radiation response of human normal fibroblasts and colon adenocarcinoma cells.
    Zaffaroni N; Villa R; Orlandi L; De Pascale A; Del Mastro S; Silvestrini R
    Radiat Res; 1993 Jul; 135(1):88-92. PubMed ID: 8327666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of calmodulin antagonist on the anticancer effect of vinblastine].
    Liu SR; Zhang Y; Lu HM
    Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):680-2, 710. PubMed ID: 7866904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
    Washtien WL
    Mol Pharmacol; 1982 May; 21(3):723-8. PubMed ID: 6213845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
    Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
    Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
    Lockshin A; Giovanella BC; Mendoza JT; Warneke C; Stehlin JS
    Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH; Hoogeland MF; Fukushima M; Peters GJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
    J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.